Please login or sign up to post and edit reviews.
- Publication Date |
- Sep 04, 2019
- Episode Duration |
- 00:11:34
Biotech companies have been some of the hottest IPOs in recent years. This week, Josh Nathan-Kasiz joins host Alex Eule on The Readback to talk about one of biotech's most promising treatments. The Readback is a finance and business podcast from Barron's. Producer: Mette Lützhøft.
Learn more about your ad choices. Visit
megaphone.fm/adchoicesThis episode could use a review!
This episode could use a review! Have anything to say about it? Share your thoughts using the button below.
Submit Review